Clinical Trial Update: Liposomal Bupivacaine in Bariatric Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for liposomal bupivacaine used for analgesia in bariatric surgery completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Analgesia

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Bariatric Surgery Analgesia | Phase 2 | Status: COMPLETED | Results posted: 2019-11-04